A novel peroxisome proliferator-activated receptor α/γ agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel peroxisome proliferator-activated receptor α/γ agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells

Published:2008-02 Issue:2 Volume:19 Page:151-158
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Kao Yu-Hsun,Hsieh Hsing-Pang,Chitlimalla Santhosh Kumar,Pan Wen-Yu,Kuo Ching-Chuan,Tsai Yuan-Chin,Lin Wen-Hsing,Chuang Shuang-En,Chang Jang-Yang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference46 articles.

1. Thiazolidinediones: a new class of antidiabetic drugs;Day;Diabetic Med,1999

2. Peroxisome proliferator-activated receptor (gamma) ligands and atherosclerosis: ending the heartache;Rosen;J Clin Invest,2000

3. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo;Itami;Int J Cancer,2001

4. Expression of peroxisome proliferator-activated receptor (PPAR) gamma in gastric cancer and inhibitory effects of PPAR gamma agonists;Sato;Br J Cancer,2000

5. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo;Yu;Hepatology,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The recent progress of isoxazole in medicinal chemistry;Bioorganic & Medicinal Chemistry;2018-07

2. Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents;ACS Medicinal Chemistry Letters;2016-09-23

3. Type II diabetes increases mitochondrial DNA mutations in the left ventricle of the Goto-Kakizaki diabetic rat;American Journal of Physiology-Heart and Circulatory Physiology;2013-04-01

4. Reaction of Nitrile Oxides with Maskedo-Benzoquinones; Synthesis of Highly Functionalized Isoxazolines;European Journal of Organic Chemistry;2013-03-08

5. Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy;Chemical Reviews;2012-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3